Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Milestone Scientific (MLSS) Other financing activities (2016 - 2025)

Milestone Scientific's Other financing activities history spans 10 years, with the latest figure at $363082.0 for Q3 2025.

  • For Q3 2025, Other financing activities fell 25.0% year-over-year to $363082.0; the TTM value through Sep 2025 reached $213228.0, down 80.71%, while the annual FY2024 figure was $364953.0, 12.59% down from the prior year.
  • Other financing activities for Q3 2025 was $363082.0 at Milestone Scientific, up from $159679.0 in the prior quarter.
  • Across five years, Other financing activities topped out at $484078.0 in Q3 2024 and bottomed at -$640320.0 in Q4 2024.
  • The 5-year median for Other financing activities is $88746.5 (2021), against an average of $111468.8.
  • The largest YoY upside for Other financing activities was 868.16% in 2024 against a maximum downside of 740.32% in 2024.
  • A 5-year view of Other financing activities shows it stood at $77493.0 in 2021, then crashed by 48.38% to $40000.0 in 2022, then surged by 150.0% to $100000.0 in 2023, then plummeted by 740.32% to -$640320.0 in 2024, then skyrocketed by 156.7% to $363082.0 in 2025.
  • Per Business Quant, the three most recent readings for MLSS's Other financing activities are $363082.0 (Q3 2025), $159679.0 (Q2 2025), and $330787.0 (Q1 2025).